Celiac disease and HLA DQ in patients with IgA nephropathy

American Journal of Gastroenterology

Volumn 97, Issue 10, 2002, Pages 2572-2576

  Collin, Pekka ^a,b,c   Syrjänen, Jaana ^a,b   Partanen, Jukka ^a,b   Pasternack, Amos ^a,b   Kaukinen, Katri ^a,b   Mustonen, Jukka ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

^c Medical School   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ANTIBODY; ENDOMYSIUM ANTIBODY; HLA DQ ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ARTICLE; CADAVER; CELIAC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GENETIC SUSCEPTIBILITY; GLUTEN FREE DIET; HAPLOTYPE; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOGLOBULIN A NEPHROPATHY; INTESTINE BIOPSY; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; SCREENING; SEROLOGY;

EID: 0036790637     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04383-6     Document Type: Article

References (40)

1. Sollid LM, Markussen G, Ek J, et al. Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer. J Exp Med 1989;169:345-50.
2. Dalton TA, Bennet JC. Autoimmune disease and major histocompatibility complex: Therapeutic implications. Am J Med 1992;92:183-8.
3. Ramala I, Collin P, Holm K, et al. Small bowel T cells, HLA class II antigen DR, and GroEL stress protein in IgA nephropathy. Kidney Int 1999;55:2274-80.
4. Helin H, Mustonen J, Reunala T, et al. IgA nephropathy associated with celiac disease and dermatitis herpetiformis. Arch Pathol Lab Med 1983;107:324-7.
5. Fornasieri A, Sinico RA, Maldifassi P, et al. IgA-antigliadin antibodies in IgA mesangial nephropathy (Berger's disease). Br Med J 1987;295:78-80.
6. Woodrow G, Innes A, Boyd SM, et al. A case of IgA nephropathy with coeliac disease responding to a gluten-free diet. Nephrol Dial Transplant 1993;8:1382-3.
7. Coppo R, Mazzucco G, Martina G, et al. Gluten-induced experimental IgA glomerulopathy. Lab Invest 1989;60:499-506.
8. Emancipator SN, Ovary Z, Lamm ME. The role of mesangial complement in the hematuria of experimental IgA nephropathy. Lab Invest 1987;57:269-76.
9. Coppo R, Basolo B, Rollino C, et al. Dietary gluten and primary IgA nephropathy. N Engl J Med 1986;315:1167-8.
10. Fennesy M, Hitman GA, Moore RH, et al. HLA-DQ gene polymorphism in primary IgA nephropathy in three European populations. Kidney Int 1996;49:477-80.
11. Pasternack A, Collin P, Mustonen J, et al. Glomerular IgA deposits in patients with celiac disease. Clin Nephrol 1990;34:56-60.
12. Collin P, Reunala T, Pukkala E, et al. Coeliac disease-associated disorders and survival. Gut 1994;35:1215-8.
13. Bottaro G, Cataldo F, Rotolo N, et al. The clinical pattern of subclinical/silent celiac disease: An analysis on 1026 consecutive cases. Am J Gastroenterol 1999;94:691-6.
14. Sategna-Guidetti C, Ferfoglia G, Bruno M, et al. Do IgA antigliadin and IgA antiendomysium antibodies show there is latent coeliac disease in primary IgA nephropathy? Gut 1992;33:476-8.
15. Rostoker G, Laurent J, Andre C, et al. High levels of IgA antigliadin antibodies in patients who have IgA mesangial glomerulonephritis but not coeliac disease. Lancet 1988;1:356-7.
16. Catassi C, Rätsch IM, Fabiani E, et al. Coeliac disease in the year 2000: Exploring the iceberg. Lancet 1994;343:200-3.
17. Johnston SD, Watson RGP, McMillan SA, et al. Prevalence of coeliac disease in Northern Ireland. Lancet 1997;350:1370.
18. Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: An improved method. Gut 1994;35:776-8.
19. Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998:115:1322-8.
20. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992;102:330-54.
21. Ots M, Uibo O, Metskula K, et al. IgA-antigliadin antibodies in patients with IgA nephropathy: The secondary phenomenon. Am J Nephrol 1999;19:453-8.
22. Koop I, Ilchmann R, Izzi L, et al. Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis. Am J Gastroenterol 2000;95:2009-14.
23. Martini S, Mengozzi G, Aimo G, et al. Diagnostic accuracies of four tissue transglutaminase autoantibody tests using human antigen. Clin Chem 2001;47:1722-5.
24. Zhong F, McCombs CC, Olson JM, et al. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland. Nature Genet 1996;14:329-33.
25. Greco L, Corazza G, Babron M-C, et al. Genome search in celiac disease. Am J Hum Genet 1998;62:669-75.
26. Houlston RS, Tomlinson IP, Ford D, et al. Linkage analysis of candidate regions for coeliac disease genes. Hum Mol Genet 1997;6:1335-9.
27. Holopainen P, Mustalahti K, Uimari P, et al. Candidate gene regions and genetic heterogeneity in gluten sensitivity. Gut 2001;48:696-701.
28. Logan RFA, Ferguson A, Finlayson NDC, et al. Primary biliary cirrhosis and coeliac disease. Lancet 1978;4:230-3.
29. Kingham JGC, Parker DR. The association between primary biliary cirrhosis and coeliac disease: A study of relative prevalence. Gut 1998;42:120-2.
30. Dickey W, McMillan SA, Calleder ME. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol 1997;25:328-9.
31. Sorensen HT, Thulstrup AM, Blomqvist P, et al. Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut 1999;44:736-8.
32. Neuberger J. PBC and the gut: The villi atrophy, the plot thickens. Gut 1999;44:594-5.
33. Meddings JB, Jarand S, Urbanski SJ, et al. Increased gastrointestinal permeability in an early lesion in the spontaneously diabetic BB rat. Am J Physiol 1999;276:G951-7.
34. Bjarnason I, Peters TJ. In vitro determination of small intestinal permeability: Demonstration of a persistent defect in patients with coeliac disease. Gut 1984;25:145-50.
35. Kovacs T, Kun L, Schmelczer M, et al. Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy? Am J Nephrol 1996;16:500-5.
36. Rostoker G, Wirquin V, Terzidix H, et al. Mucosal immunity in primary glomerulonephritis. Nephron 1993;63:286-90.
37. Lundin KEA, Scott H, Hansen T, et al. Gliadin-specific, HLA- DQ(α1*0501, β1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993;178:87-96.
38. Sollid LM, Molberg O, McAdam S, et al. Autoantibodies in coeliac disease: Tissue transglutaminase-guilt by association. Gut 1997;41:851-2.
39. Pender SL, Tickle SP, Docherty AJ, et al. A role of matrix metalloproteinases in T cell injury in the gut. J Immunol 1997;158:1582-90.
40. Fasano A, Not T, Wang W, et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000;355:1518-9.